Oruka Therapeutics, Inc. ORKA Number of Exercisable Options
Number of Exercisable Options at other companies
Other financials
Where this comes from
Reported directly by Oruka Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue.
The official record: Oruka Therapeutics, Inc.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Oruka Therapeutics, Inc.'s number of exercisable options.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Oruka Therapeutics, Inc.'s number of exercisable options?
- Oruka Therapeutics, Inc. (ORKA) reported number of exercisable options of $160.99M in Q1 2026.
- How has Oruka Therapeutics, Inc.'s number of exercisable options changed year-over-year?
- Oruka Therapeutics, Inc.'s number of exercisable options increased by 3322.3% year-over-year, from $4.7M to $160.99M.
- What does number of exercisable options mean?
- The number of share-based payment options that have met all vesting requirements and are currently eligible for exercise by the holders. This represents the portion of the equity incentive pool that could be converted into common stock immediately. It is a critical component for calculating fully diluted share counts.